The inability of wild-type rabies virus to activate dendritic cells is dependent on the glycoprotein and correlates with its low level of the de novo-synthesized leader RNA

Journal of Virology

Volumn 89, Issue 4, 2015, Pages 2157-2169

  Yang, Yang ^a,b   Huang, Ying ^b   Gnanadurai, Clement W ^b   Cao, Shengbo ^a   Liu, Xueqin ^b   Cui, Min ^a   Fu, Zhen F ^a,b  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; NEUTRALIZING ANTIBODY; RNA; 5' UNTRANSLATED REGION; VIRUS RNA;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CORRELATION ANALYSIS; DENDRITIC CELL; DOSE RESPONSE; GENETIC TRANSFECTION; IN VITRO STUDY; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; RABIES VIRUS; RNA SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS ATTACHMENT; VIRUS ATTENUATION; VIRUS ENTRY; VIRUS RECOMBINANT; WILD TYPE; 5' UNTRANSLATED REGION; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; VIROLOGY;

RABIES VIRUS;

5' UNTRANSLATED REGIONS; ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; GLYCOPROTEINS; MICE, INBRED BALB C; RABIES VIRUS; RNA, VIRAL;

EID: 84921683852     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02092-14     Document Type: Article

References (62)

1. WHO. 2005. WHO expert consultation on rabies. World Health Organ Tech Rep Series 931:1-88.
2. Wunner WH, Larson JK, Dietzschold B, Smith CL. 1988. The molecular-biology of rabies viruses. Rev Infect Dis 10:S771-S784. http://dx.doi.org/10.1093/clinids/10.Supplement_4.S771.
3. Cox JH, Dietzschold B, Schneider LG. 1977. Rabies virus glycoprotein. II. Biological and serological characterization. Infect Immun 16:754-759.
4. Lentz TL, Burrage TG, Smith AL, Tignor GH. 1983. The acetylcholinereceptor as a cellular receptor for rabies virus. Yale J Biol Med 56:315-322.
5. Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cremer H, Lafon M. 1998. The neural cell adhesion molecule is a receptor for rabies virus. J Virol 72:7181-7190.
6. Benmansour A, Leblois H, Coulon P, Tuffereau C, Gaudin Y, Flamand A, Lafay F. 1991. Antigenicity of rabies virus glycoprotein. J Virol 65: 4198-4203.
7. Lafon M, Wiktor TJ, Macfarlan RI. 1983. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J Gen Virol 64(Part 4):843-851.
8. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H. 1983. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80:70-74. http://dx.doi.org/10.1073/pnas.80.1.70.
9. Hemachudha T. 1994. Human rabies: clinical aspects, pathogenesis, and potential therapy. Curr Topics Microbiol Immunol 187:121-143.
10. Wang H, Zhang G, Wen Y, Yang S, Xia X, Fu ZF. 2011. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus. PLoS One 6:e25414. http://dx.doi.org/10.1371/journal.pone.0025414.
11. Gnanadurai CW, Zhou M, He W, Leyson CM, Huang CT, Salyards G, Harvey SB, Chen Z, He B, Yang Y, Hooper DC, Dietzchold B, Fu ZF. 2013. Presence of virus neutralizing antibodies in cerebral spinal fluid correlates with non-lethal rabies in dogs. PLoS Negl Trop Dis 7:e2375. http://dx.doi.org/10.1371/journal.pntd.0002375.
12. Tolson ND, Charlton KM, Lawson KF, Campbell JB, Stewart RB. 1988. Studies of ERA/BHK-21 rabies vaccine in skunks and mice. Can J Vet Res 52:58-62.
13. Zhou M, Zhang GQ, Ren GP, Gnanadurai CW, Li ZG, Chai QQ, Yang Y, Leyson CM, Wu WX, Cui M, Fu ZF. 2013. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. PLoS One 8:e63384. http://dx.doi.org/10.1371/journal.pone.0063384.
14. Zhao L, Toriumi H, Wang HL, Kuang Y, Guo XF, Morimoto K, Fu ZF. 2010. Expression of MIP-1 alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells. J Virol 84:9642-9648. http://dx.doi.org/10.1128/JVI.00326-10.
15. Wen Y, Wang H, Wu H, Yang F, Tripp RA, Hogan RJ, Fu ZF. 2011. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol 85:1634-1644. http://dx.doi.org/10.1128/JVI.01552-10.
16. Rupprecht CE, Hanlon CA, Blanton J, Manangan J, Morrill P, Murphy S, Niezgoda M, Orciari LA, Schumacher CL, Dietzschold B. 2005. Oral vaccination of dogs with recombinant rabies virus vaccines. Virus Res 111:101-105. http://dx.doi.org/10.1016/j.virusres.2005.03.017.
17. Li JW, Ertel A, Portocarrero C, Barkhouse DA, Dietzschold B, Hooper DC, Faber M. 2012. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the central nervous system (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues. J Virol 86:3200-3210. http://dx.doi.org/10.1128/JVI.06699-11.
18. Kuang Y, Lackay SN, Zhao L, Fu ZF. 2009. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res 144:18-26. http://dx.doi.org/10.1016/j.virusres.2009.03.014.
19. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, Jiang B, Fu ZF. 2005. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79:12554-12565. http://dx.doi.org/10.1128/JVI.79.19.12554-12565.2005.
20. Johnson N, Cunningham AF, Fooks AR. 2010. The immune response to rabies virus infection and vaccination. Vaccine 28:3896-3901. http://dx.doi.org/10.1016/j.vaccine.2010.03.039.
21. Prehaud C, Megret F, Lafage M, Lafon M. 2005. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 79:12893-12904. http://dx.doi.org/10.1128/JVI.79.20.12893-12904.2005.
22. Zhao L, Toriumi H, Kuang Y, Chen HC, Fu ZF. 2009. The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J Virol 83:11808-11818. http://dx.doi.org/10.1128/JVI.01346-09.
23. Becker Y. 2003. Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells-a review. Virus Genes 26:119-130. http://dx.doi.org/10.1023/A:1023427228024.
24. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811. http://dx.doi.org/10.1146/annurev.immunol.18.1.767.
25. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. http://dx.doi.org/10.1038/32588.
26. Reis e Sousa C, Stahl PD, Austyn JM. 1993. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178:509-519. http://dx.doi.org/10.1084/jem.178.2.509.
27. Heath WR, Belz GT, Behrens GMN, Smith CM, Forehan SP, Parish IA, Davey GM, Wilson NS, Carbone FR, Villadangos JA. 2004. Crosspresentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199:9-26. http://dx.doi.org/10.1111/j.0105-2896.2004.00142.x.
28. Li J, McGettigan JP, Faber M, Schnell MJ, Dietzschold B. 2008. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway. Vaccine 26:419-426. http://dx.doi.org/10.1016/j.vaccine.2007.10.072.
29. Faul EJ, Wanjalla CN, Suthar MS, Gale M, Wirblich C, Schnell MJ. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog 6:e1001016. http://dx.doi.org/10.1371/journal.ppat.1001016.
30. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997. http://dx.doi.org/10.1126/science.1132505.
31. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
32. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702. http://dx.doi.org/10.1084/jem.176.6.1693.
33. Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B. 1999. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol 73:510-518.
34. Dietzschold B, Morimoto K, Hooper DC, Smith JS, Rupprecht CE, Koprowski H. 2000. Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J Hum Virol 3:50-57.
35. Zhang GQ, Wang HL, Mahmood F, Fu ZF. 2013. Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms. Vet Microbiol 162:601-613. http://dx.doi.org/10.1016/j.vetmic.2012.11.031.
36. Niu X, Tang L, Tseggai T, Guo Y, Fu ZF. 2013. Wild-type rabies virus phosphoprotein is associated with viral sensitivity to type I interferon treatment. Arch Virol 158:2297-2305. http://dx.doi.org/10.1007/s00705-013-1743-2.
37. Sarmento L, Li ZQ, Howerth E, Jackson AC, Fu ZF. 2005. Glycoproteinmediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice. J Neurovirol 11:571-581. http://dx.doi.org/10.1080/13550280500385310.
38. Finke S, Conzelmann KK. 1997. Ambisense gene expression from recombinant rabies virus: random packaging of positive-and negative-strand ribonucleoprotein complexes into rabies virions. J Virol 71:7281-7288.
39. Pawan JL. 1959. Rabies in the vampire bat of Trinidad, with special reference to the clinical course and the latency of infection. Caribb Med J 21:137-156.
40. Fekadu M. 1988. Pathogenesis of rabies virus infection in dogs. Rev Infect Dis 10(Suppl 4):S678-S683. http://dx.doi.org/10.1093/clinids/10.Supplement_4.S678.
41. Hemachudha T, Phanuphak P, Sriwanthana B, Manutsathit S, Phanthumchinda K, Siriprasomsup W, Ukachoke C, Rasameechan S, Kaoroptham S. 1988. Immunologic study of human encephalitic and paralytic rabies. Preliminary report of 16 patients. Am J Med 84:673-677.
42. Steinman RM. 2007. Dendritic cells: understanding immunogenicity. Eur J Immunol 37(Suppl 1):S53-S60. http://dx.doi.org/10.1002/eji.200737400.
43. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, Bhardwaj N. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J Immunol 163:6762-6768.
44. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. 2002. Human cytomegalovirus inhibits maturation and impairs function of monocytederived dendritic cells. Blood 99:2913-2921. http://dx.doi.org/10.1182/blood.V99.8.2913.
45. Salio M, Cella M, Suter M, Lanzavecchia A. 1999. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 29:3245-3253.
46. Faber M, Pulmanausahakul R, Hodawadekar SS, Spitsin S, McGettigan JP, Schnell MJ, Dietzschold B. 2002. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 76:3374-3381. http://dx.doi.org/10.1128/JVI.76.7.3374-3381.2002.
47. Sarmento L, Tseggai T, Dhingra V, Fu ZF. 2006. Rabies virus-induced apoptosis involves caspase-dependent and caspase-independent pathways. Virus Res 121:144-151. http://dx.doi.org/10.1016/j.virusres.2006.05.002.
48. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001. http://dx.doi.org/10.1126/science.1132998.
49. Lawrence TM, Hudacek AW, de Zoete MR, Flavell RA, Schnell MJ. 2013. Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1beta release in murine dendritic cells. J Virol 87:5848-5857. http://dx.doi.org/10.1128/JVI.00203-13.
50. Plumet S, Herschke F, Bourhis JM, Valentin H, Longhi S, Gerlier D. 2007. Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One 2:e279. http://dx.doi.org/10.1371/journal.pone.0000279.
51. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, Lammens K, Fujita T, Conzelmann KK, Krug A, Hopfner KP. 2008. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell 29:169-179. http://dx.doi.org/10.1016/j.molcel.2007.10.032.
52. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
53. Forsbach A, Nemorin JG, Volp K, Samulowitz U, Montino C, Muller C, Tluk S, Hamm S, Bauer S, Lipford GB, Vollmer J. 2007. Characterization of conserved viral leader RNA sequences that stimulate innate immunity through TLRs. Oligonucleotides 17:405-417. http://dx.doi.org/10.1089/oli.2007.0098.
54. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988. http://dx.doi.org/10.1038/ni1243.
55. Helin E, Vainionpaa R, Hyypia T, Julkunen I, Matikainen S. 2001. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology 290:1-10. http://dx.doi.org/10.1006/viro.2001.1174.
56. Ogino T, Yadav SP, Banerjee AK. 2010. Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci USA 107:3463-3468. http://dx.doi.org/10.1073/pnas.0913083107.
57. Ogino T, Banerjee AK. 2010. The HR motif in the RNA-dependent RNA polymerase L protein of Chandipura virus is required for unconventional mRNA-capping activity. J Gen Virol 91:1311-1314. http://dx.doi.org/10.1099/vir.0.019307-0.
58. Moyer SA, Abraham G, Adler R, Banerjee AK. 1975. Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell 5:59-67. http://dx.doi.org/10.1016/0092-8674(75)90092-6.
59. Gerlier D, Lyles DS. 2011. Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev 75:468-490. http://dx.doi.org/10.1128/MMBR.00007-11.
60. Habjan M, Andersson I, Klingstrom J, Schumann M, Martin A, Zimmermann P, Wagner V, Pichlmair A, Schneider U, Muhlberger E, Mirazimi A, Weber F. 2008. Processing of genome 5' termini as a strategy of negativestrand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 3:e2032. http://dx.doi.org/10.1371/journal.pone.0002032.
61. Yan X, Prosniak M, Curtis MT, Weiss ML, Faber M, Dietzschold B, Fu ZF. 2001. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J Neurovirol 7:518-527. http://dx.doi.org/10.1080/135502801753248105.
62. Wirblich C, Schnell MJ. 2011. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. J Virol 85:697-704. http://dx.doi.org/10.1128/JVI.01309-10.